Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; HIV-2

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87391 refers to the detection of the HIV-2 antigen using various immunoassay techniques. This procedure involves testing a blood or saliva sample to identify the presence of the human immunodeficiency virus type 2 (HIV-2) antigen. The immunoassay techniques utilized in this process include enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and immunochemiluminometric assay (IMCA). These methods are designed to detect even minute quantities of the HIV-2 antigen by employing specific antibodies that bind to the antigen in the sample. HIV-2 is a variant of the HIV virus that can lead to acquired immunodeficiency syndrome (AIDS), a condition characterized by the progressive failure of the immune system. The virus is primarily transmitted through sexual contact, but it can also be spread through unscreened blood transfusions, sharing of needles, and from mother to child during childbirth or breastfeeding. The testing process begins with the collection of a sample, which is then processed in a laboratory setting. The immunoassay techniques work by introducing a secondary enzyme-labeled antibody that binds to the antigen, resulting in a chromogenic reaction that produces a visible color change or fluorescence, indicating the presence of the HIV-2 antigen. The results can be reported as qualitative, indicating the presence or absence of the antigen, or semi-quantitative, providing a measure of the antigen concentration based on colorimetric readings. This code is specifically used for testing HIV-2, distinguishing it from other related codes that pertain to HIV-1 testing.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 87391 is indicated for the detection of the HIV-2 antigen in individuals who may be at risk for HIV infection. The following conditions or situations warrant the use of this test:

  • Risk of HIV-2 Infection Individuals who have engaged in high-risk behaviors, such as unprotected sexual intercourse with an HIV-positive partner or sharing needles, may require testing for HIV-2.
  • Symptoms of HIV Infection Patients presenting with symptoms suggestive of HIV infection, such as unexplained weight loss, persistent fever, night sweats, or swollen lymph nodes, may be tested to confirm or rule out HIV-2.
  • Pregnancy Pregnant women may be tested for HIV-2 to prevent mother-to-child transmission during childbirth or breastfeeding.
  • Screening in High-Prevalence Areas Individuals living in or traveling to regions where HIV-2 is more prevalent may be screened as part of routine health assessments.

2. Procedure

The procedure for CPT® Code 87391 involves several key steps to ensure accurate detection of the HIV-2 antigen:

  • Sample Collection A blood or saliva sample is collected from the patient. The sample must be handled carefully, either placed in a fixative or sent fresh to the laboratory for processing to maintain the integrity of the antigen.
  • Preparation of the Sample In the laboratory, the sample is prepared for testing. This may involve centrifugation of blood samples to separate plasma or serum, depending on the specific immunoassay technique being used.
  • Immunoassay Technique Application The prepared sample is subjected to one of the immunoassay techniques, such as EIA, ELISA, FIA, or IMCA. Each technique utilizes specific antibodies that bind to the HIV-2 antigen present in the sample.
  • Detection and Measurement Following the binding of the antibodies to the antigen, a secondary enzyme-labeled antibody is added. This antibody reacts with the antigen-antibody complex, resulting in a chromogenic reaction that produces a visible color change or fluorescence. The intensity of the color or fluorescence is measured to determine the presence and quantity of the HIV-2 antigen.
  • Result Interpretation The results are then interpreted as either qualitative, indicating the presence or absence of the HIV-2 antigen, or semi-quantitative, providing a measure of the antigen concentration based on the colorimetric reading.

3. Post-Procedure

After the procedure associated with CPT® Code 87391, the patient may receive counseling regarding the results of the test. If the test is positive, further confirmatory testing and medical evaluation are typically recommended to assess the patient's health status and determine the appropriate course of treatment. Patients may also be advised on preventive measures to reduce the risk of transmission. It is essential for healthcare providers to ensure that patients understand the implications of their test results and the importance of follow-up care. Additionally, patients should be informed about the potential for false positives or negatives and the need for retesting in certain circumstances.

Short Descr HIV-2 AG IA
Medium Descr IAAD IA HIV-2
Long Descr Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-2
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
Date
Action
Notes
2022-01-01 Changed First appearance of change in codebook.
2022-01-01 Note Grammatical correction.
2021-01-01 Changed First appearance of change in CPT® Code Set.
2020-10-06 Changed Code changed.
2016-01-01 Changed Description Changed
2011-01-01 Changed Short description changed.
2007-01-01 Changed Code description changed.
1998-01-01 Added First appearance in code book in 1998.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"